3rd Quarter - Report

SIDLEY AUSTIN LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 15, 2009 $30,000 Replaced
3rd Quarter - Report Oct 30, 2009 $30,000 Replaced
3rd Quarter - Amendment Oct 30, 2009 $30,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care reform, H.R. 3200

LobbyistCovered position, as disclosed
JOHN P FORD New Sr. Counsel, House Energy & Commerce

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO)

Bills named: H.R. 3200 (111th)

Trade (domestic/foreign) TRD

WTO enforcement actions on intellectual property; pharmaceutical industry issues pertinent in WTO and FTA negotiations and implementation

LobbyistCovered position, as disclosed
JEFFREY P KUSHAN N/A
JON P SANTAMAURO New N/A
ANDREW W SHOYER N/A

Contacted: Treasury, Dept of; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); SENATE; State, Dept of (DOS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.